Literature DB >> 26485702

Determinants of Frailty and Longevity: Are They the Same Ones?

Leocadio Rodríguez Mañas.   

Abstract

Older people are at risk of developing frailty with advancing age. The prevalence of frailty increases from 2.5-3% in adults aged 65 years to 30-35% in those older than 85 years. These results suggest that an association exists between longevity and frailty. However, at the same time, even at advanced age, the majority of older adults are free of frailty, suggesting that factors different from those contributing to or produced by the life length are involved in producing frailty. Genetic and epigenetic factors, nutrient-sensing systems, mainly the so-called insulin/insulin-like growth factor-1 signaling pathway, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, inflammation, and some hormonal systems are involved in longevity. However, factors involved in frailty are mainly inflammation and hormones, with an anecdotal role for genetic and other potential factors, but even these two common factors seem to regulate longevity and frailty in different ways. Moreover, their effect on frailty seems to change when they are acting in combination.
© 2015 Nestec Ltd., Vevey/S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26485702     DOI: 10.1159/000382057

Source DB:  PubMed          Journal:  Nestle Nutr Inst Workshop Ser        ISSN: 1664-2147


  8 in total

1.  Assessment of the role of ageing and non-ageing factors in death from non-communicable diseases based on a cumulative frequency model.

Authors:  Liu Hui
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

2.  Frailty syndrome and rehospitalizations in elderly heart failure patients.

Authors:  Izabella Uchmanowicz; Maria Kuśnierz; Marta Wleklik; Beata Jankowska-Polańska; Joanna Jaroch; Krystyna Łoboz-Grudzień
Journal:  Aging Clin Exp Res       Date:  2017-08-28       Impact factor: 3.636

3.  Modified frailty as a novel factor in predicting the response to cardiac resynchronization in the elderly population.

Authors:  Agnieszka Mlynarska; Rafal Mlynarski; Czeslaw Marcisz; Krzysztof S Golba
Journal:  Clin Interv Aging       Date:  2019-02-25       Impact factor: 4.458

4.  Implications of maraviroc and/or rapamycin in a mouse model of fragility.

Authors:  Laura Pérez-Martínez; Lourdes Romero; Sandra Muñoz-Galván; Eva M Verdugo-Sivianes; Susana Rubio-Mediavilla; José A Oteo; Amancio Carnero; José-Ramón Blanco
Journal:  Aging (Albany NY)       Date:  2020-04-30       Impact factor: 5.682

5.  Association between oral health and frailty: results from the Korea National Health and Nutrition Examination Survey.

Authors:  Hyunjoo Kim; Euni Lee; Seok-Woo Lee
Journal:  BMC Geriatr       Date:  2022-04-27       Impact factor: 4.070

Review 6.  Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models.

Authors:  María Álvarez-Satta; Alejandro Berna-Erro; Estefania Carrasco-Garcia; Ainhoa Alberro; Ander Saenz-Antoñanzas; Itziar Vergara; David Otaegui; Ander Matheu
Journal:  Aging (Albany NY)       Date:  2020-05-27       Impact factor: 5.682

7.  Frailty syndrome and cognitive impairment in older adults: systematic review of the literature.

Authors:  Karen Miyamura; Jack Roberto Silva Fhon; Alexandre de Assis Bueno; Wilmer Luis Fuentes-Neira; Renata Cristina de Campos Pereira Silveira; Rosalina Aparecida Partezani Rodrigues
Journal:  Rev Lat Am Enfermagem       Date:  2019-10-28

8.  Tackling frailty at primary care: evaluation of the effectiveness of a multicomponent intervention through a randomised controlled trial: study protocol.

Authors:  Francisco Rivas-Ruiz; Mónica Machón; Maider Mateo-Abad; Eugenio Contreras-Fernández; Carolina Güell; Luis Baro-Rodríguez; Kalliopi Vrotsou; Raúl Quirós-López; Itziar Vergara
Journal:  BMJ Open       Date:  2020-02-20       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.